Piramal Pharma Share Price
(PPLPHARMA)
₹189.89
as on 04:01PM, 28 Feb 2025
Piramal Pharma Performance
Day's Low
Day's High
₹188.01Day's Price Range₹204.452 Week's Low
52 Week's High
₹114.3552-Week Price Range₹307.9
| Returns % | |
| 1 Month Return | -17.23 % |
| 3 Month Return | -30.56 % |
| 1 Year Return | + 44.79 % |
| Market Stats | |
| Previous Close | ₹204.62 |
| Open | ₹201.82 |
| Volume | 1.66Cr |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹25,174.63Cr |
Piramal Pharma Key Statistics
P/E Ratio
632.97
PEG Ratio
1090.57
Market Cap
₹25,174.63 Cr
P/B Ratio
2.54
EPS
0.13
Dividend Yield
0.09
Sector
Pharmaceuticals
ROE
6.53
Piramal Pharma Mutual Fund Holdings
Piramal Pharma Analyst Rating
based on 7 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 7 analysts offering long term price targets for Piramal Pharma. An average target of ₹304.29
Source: S&P Global Market Intelligence
Piramal Pharma Share analysis
Piramal Pharma price forecast by 7 analysts
Upside of60.25%
High
₹340
Target
₹304.29
Low
₹265
Piramal Pharma target price ₹304.29, a slight upside of 60.25% compared to current price of ₹189.89. According to 7 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Piramal Pharma revenue growth forecast
Expected growth rate Q1, FY2027:50.22%
Forecast
Actual
Including amortisation and stock based compensations
Piramal Pharma EPS growth forecast
EPS estimate Q1, FY2027:4769.23%
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Piramal Pharma Ltd
Piramal Pharma Faces Logistics and Import Challenges - 27 Feb, 2025
Nandini Piramal, Chairperson of Piramal Pharma, expressed concerns over inadequate customs warehouses, high logistics costs, insufficient cold storage, and delays in importing raw materials.Piramal Pharma Faces FDA Observations at Turbhe Facility - 18 Feb, 2025
Piramal Pharma's Turbhe facility received a Form-483 with six observations from the US FDA, primarily regarding procedural improvements. The company reported a significant decline in net profit but an increase in revenue and EBITDA for Q3 FY25.Motilal Oswal Recommends Buy on Piramal Pharma - 06 Feb, 2025
Motilal Oswal Financial Services has a buy rating on Piramal Pharma with a target price of Rs 300. The company reported a net loss of Rs 13.37 crore for the latest quarter, but its revenue showed a year-over-year increase. The brokerage raised EBITDA estimates while reducing earnings estimates due to a higher effective tax rate.
Insights on Piramal Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 11.21% to 11.66% in Dec 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 57.4% return, outperforming this stock by 12.6%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 34.95% of holdings in Dec 2024 quarter
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 2.32K Cr → 2.23K Cr (in ₹), with an average decrease of 3.7% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 22.59 Cr → 3.68 Cr (in ₹), with an average decrease of 83.7% per quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 13.73% to 13.68% in Dec 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, PPLPHARMA stock has moved down by -9.2%
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 19.07% to 18.87% in Dec 2024 quarter
Piramal Pharma Financials
Index Inclusions
Piramal Pharma Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 34.95% | 0.00 | |
| Foreign Institutions | 13.68% | ||
| Mutual Funds | 11.66% | 4.00 | |
| Retail Investors | 18.87% | ||
| Others | 20.85% |
Piramal Pharma Key Indicators
Piramal Pharma Valuation
Piramal Pharma in the last 5 years
Lowest (-516.41x)
January 5, 2024
Industry (50.30x)
February 28, 2025
Today (632.97x)
February 28, 2025
Highest (2011.42x)
June 25, 2024
Piramal Pharma Earnings and Dividends
Piramal Pharma Ltd Earnings Results
Piramal Pharma Ltd’s net profit fell -63.6% since last year same period to ₹3.68Cr in the Q3 2024-2025. On a quarterly growth basis, Piramal Pharma Ltd has generated -83.71% fall in its net profits since last 3-months.
Read More about Earnings ResultsPiramal Pharma Ltd Dividends May,2024
In the quarter ending March 2024, Piramal Pharma Ltd has declared dividend of ₹0.11 - translating a dividend yield of 0.06%.
Read More about Dividends
Piramal Pharma Technicals Summary
Bearish
Neutral
Bullish
Piramal Pharma Ltd is currently in a Bearish trading position according to technical analysis indicators.
Piramal Pharma Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹25,174.63 Cr | -0.01% | 0.58 | ₹17 Cr | ₹8,171 Cr | |
| BUY | ₹30,922.01 Cr | 124.15% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
| BUY | ₹14,380.01 Cr | 22.54% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
| NA | ₹3,647.30 Cr | -4.06% | 0.79 | -₹388 Cr | ₹75 Cr | |
| BUY | ₹12,588.35 Cr | 35.07% | 0.68 | ₹218 Cr | ₹1,296 Cr |
About Piramal Pharma
Share Price: ₹189.89 per share as on 28 Feb, 2025 04:01 PM
Market Capitalisation: ₹25,174.63Cr as of today
Revenue: ₹2,204.22Cr as on December 2024 (Q4 24)
Net Profit: ₹3.68Cr as on December 2024 (Q4 24)
Listing date: 19 Oct, 2022
Chairperson Name: Nandini Piramal
| Organisation | Piramal Pharma |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Piramal Pharma Ltd
What is Piramal Pharma Ltd price today?
Piramal Pharma Ltd share price today stands at ₹189.89, Open: ₹201.82, Previous Close: ₹204.62, High: ₹204.4, Low: ₹188.01, 52 Week High: ₹307.9, 52 Week Low: ₹114.35.
How to Buy Piramal Pharma Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Piramal Pharma Ltd shares
Is Piramal Pharma Ltd listed on NSE?
Piramal Pharma Ltd is listed on NSE
Is Piramal Pharma Ltd listed on BSE?
Piramal Pharma Ltd is listed on BSE
What are today's High and Low prices of Piramal Pharma Ltd?
- Today's highest price of Piramal Pharma Ltd is ₹204.4.
- Today's lowest price of Piramal Pharma Ltd is ₹188.01.
What are today's traded volumes of Piramal Pharma Ltd?
Today's traded volume of Piramal Pharma Ltd(PPLPHARMA) is 1.66Cr.
What is today's market capitalisation of Piramal Pharma Ltd?
Today's market capitalisation of Piramal Pharma Ltd(PPLPHARMA) is ₹25174.63Cr.
What is the 52 Week High and Low Range of Piramal Pharma Ltd?
How much percentage Piramal Pharma Ltd is down from its 52 Week High?
Piramal Pharma Ltd (PPLPHARMA) share price is ₹189.89. It is down -38.33% from its 52 Week High price of ₹307.9
How much percentage Piramal Pharma Ltd is up from its 52 Week low?
Piramal Pharma Ltd (PPLPHARMA) share price is ₹189.89. It is up 66.06% from its 52 Week Low price of ₹114.35
What are the historical returns of Piramal Pharma Ltd?
What is the PE ratio of Piramal Pharma Ltd today?
PE Ratio of Piramal Pharma Ltd is 632.97
PE ratio = Piramal Pharma Ltd Market price per share / Piramal Pharma Ltd Earnings per share